Skip to Content

Customized Stem Cells

Reprogramming cells taken from disease sufferers could lead to new treatments.
February 19, 2008

The discovery late last year of a way to generate stem cells from adult skin cells could allow scientists to study disease in unprece­dented detail, from earliest inception to final biochemi­cal demise. That’s because the stem cells could be used to develop cell lines derived from people with a given disease–neurons from Alzheimer’s patients, for example, or blood cells from people with sickle-cell ­anemia. The resulting trove of cells would capture all the genetic quirks of these complex diseases.

By comparing the development and behavior of cells derived from healthy and diseased people, scientists could determine how disease unfolds at a cellular level, identifying points in the process where intervention might do some good. They could also use the cells to test drugs that might correct biochemical abnormalities. “We want to use these cells to ask and answer questions that can’t be asked and answered any other way,” says M. ­William Lensch, a scientist at the Harvard Stem Cell Institute.

Lensch and collaborators in George Daley’s lab at Children’s Hospital in Boston are attempting to create stem-cell lines using tissue samples collected from people with Huntington’s disease, sickle-cell anemia, and another blood disease called Fanconi anemia. Other scientists are expected to follow suit, investigating other diseases.

Credit: Tami Tolpa

1. A biopsy extracts skin cells from an Alzheimer’s patient.

2. Scientists use viruses to insert four genes–normally expressed in developing embryos–into the cells.

3. These genes manage to reprogram some of the cells to turn into colonies of ­embryonic stem cells.

4. Exposure to ­specific chemicals then coaxes the cells to grown into neurons.

Keep Reading

Most Popular

10 Breakthrough Technologies 2024

Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

AI for everything: 10 Breakthrough Technologies 2024

Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.

What’s next for AI in 2024

Our writers look at the four hot trends to watch out for this year

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.